NCT05140018 - Incidence, Course and Outcome of ABMR in Kidney Transplantation | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

March 1, 2026

Conditions

Antibody-mediated RejectionKidney TransplantationImmunosuppression

Interventions

PROCEDURE

Kidney Transplantation

All participants will receive a kidney transplantation from a living donor or deceased donor

COMBINATION_PRODUCT

Immunosuppression

All participants will receive immunosuppresive drugs to prevent rejection of de kidney transplant graft.

PROCEDURE

Nephrectomy (kidney donation)

All kidney donors will receive a nephrectomy for kidney donation

Trial Locations (6)

RECRUITING

Academisch Medisch Centrum, Amsterdam

RECRUITING

University Medical Center Groningen, Groningen

RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Radboud University Hospital, Nijmegen

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

UMCU, Utrecht